These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25159064)

  • 1. Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach.
    Munisi HI; Xie Z; Sengoku S
    Regen Med; 2014; 9(4):467-77. PubMed ID: 25159064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japan's patent issues relating to life science therapeutic inventions.
    Tessensohn JA
    Expert Opin Ther Pat; 2014 Sep; 24(9):953-7. PubMed ID: 25089628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell research and regenerative medicine in 2014: first year of regenerative medicine in Japan.
    Okano H
    Stem Cells Dev; 2014 Sep; 23(18):2127-8. PubMed ID: 25192239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Netherlands advancing to the forefront of regenerative medicine.
    Gielen K
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():29-31. PubMed ID: 25457958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells have the potential to rejuvenate regenerative medicine research.
    Eve DJ; Fillmore R; Borlongan CV; Sanberg PR
    Med Sci Monit; 2010 Oct; 16(10):RA197-217. PubMed ID: 20885363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for stem cell patent applications in the light of recent court cases.
    Eyre DE; Schlich GW
    Pharm Pat Anal; 2015; 4(6):431-41. PubMed ID: 26580992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products.
    Bayon Y; Vertès AA; Ronfard V; Culme-Seymour E; Mason C; Stroemer P; Najimi M; Sokal E; Wilson C; Barone J; Aras R; Chiesi A
    Tissue Eng Part B Rev; 2015 Dec; 21(6):560-71. PubMed ID: 26179129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging.
    Solanki A; Kim JD; Lee KB
    Nanomedicine (Lond); 2008 Aug; 3(4):567-78. PubMed ID: 18694318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intellectual Property in the Field of Regenerative Medicine in Japan.
    Asano S; Nakanishi Y; Sugiyama D
    Clin Ther; 2018 Nov; 40(11):1823-1827. PubMed ID: 30458929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalyzing stem cell research.
    Willemse L; Lyall D; Rudnicki M
    Regen Med; 2008 Sep; 3(5):761-4. PubMed ID: 18729799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Social Framework Surrounding the Development of Regenerative Medicine in Japan.
    Nakazawa E; Takimoto Y; Akabayashi A
    Camb Q Healthc Ethics; 2016 Jul; 25(3):466-71. PubMed ID: 27348830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inherent ethical challenge of first-in-human pluripotent stem cell trials.
    Habets MG; van Delden JJ; Bredenoord AL
    Regen Med; 2014 Jan; 9(1):1-3. PubMed ID: 24350999
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical control of stem cell fate and developmental potential.
    Lyssiotis CA; Lairson LL; Boitano AE; Wurdak H; Zhu S; Schultz PG
    Angew Chem Int Ed Engl; 2011 Jan; 50(1):200-42. PubMed ID: 21184400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting justice in stem cell intellectual property.
    Regenberg A; Mathews DJ
    Regen Med; 2011 Nov; 6(6 Suppl):79-84. PubMed ID: 21999266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of stem cells and regenerative medicine research in Argentina.
    Pitossi FJ; Podhajcer OL
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():17-9. PubMed ID: 25457955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protecting methods for treatment related to regenerative medicine and gene therapy in Japan.
    Kaneshiro K; Masuda S; Tanaka Y; Tamai K
    Nat Biotechnol; 2004 Mar; 22(3):343-5. PubMed ID: 14990960
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem cells create a therapeutic niche.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926
    [No Abstract]   [Full Text] [Related]  

  • 18. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada.
    Roy DC; Alarco AM; Isasi R
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative medicine: a reality of stem cell technology.
    Terzic A; Edwards BS; McKee KC; Nelson TJ
    Minn Med; 2011 May; 94(5):44-7. PubMed ID: 21707014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine.
    Ratcliffe E; Thomas RJ; Williams DJ
    Br Med Bull; 2011; 100():137-55. PubMed ID: 21852279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.